Suppr超能文献

年轻乳腺癌女性对基因组测序结果回报最感兴趣的信息主题。

Information Topics of Greatest Interest for Return of Genome Sequencing Results among Women Diagnosed with Breast Cancer at a Young Age.

作者信息

Seo Joann, Ivanovich Jennifer, Goodman Melody S, Biesecker Barbara B, Kaphingst Kimberly A

机构信息

Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, 660 S. Euclid Avenue, Campus Box 8100, St. Louis, MO, 63110, USA.

Social and Behavioral Research Branch, National Human Genome Research Institute, Bethesda, MD, USA.

出版信息

J Genet Couns. 2017 Jun;26(3):511-521. doi: 10.1007/s10897-016-0006-2. Epub 2016 Aug 20.

Abstract

We investigated what information women diagnosed with breast cancer at a young age would want to learn when genome sequencing results are returned. We conducted 60 semi-structured interviews with women diagnosed with breast cancer at age 40 or younger. We examined what specific information participants would want to learn across result types and for each type of result, as well as how much information they would want. Genome sequencing was not offered to participants as part of the study. Two coders independently coded interview transcripts; analysis was conducted using NVivo10. Across result types, participants wanted to learn about health implications, risk and prevalence in quantitative terms, causes of variants, and causes of diseases. Participants wanted to learn actionable information for variants affecting risk of preventable or treatable disease, medication response, and carrier status. The amount of desired information differed for variants affecting risk of unpreventable or untreatable disease, with uncertain significance, and not health-related. Women diagnosed with breast cancer at a young age recognize the value of genome sequencing results in identifying potential causes and effective treatments and expressed interest in using the information to help relatives and to further understand their other health risks. Our findings can inform the development of effective feedback strategies for genome sequencing that meet patients' information needs and preferences.

摘要

我们调查了年轻时被诊断出患有乳腺癌的女性在收到基因组测序结果时想要了解哪些信息。我们对60名年龄在40岁及以下且被诊断出患有乳腺癌的女性进行了半结构化访谈。我们研究了参与者在不同结果类型中以及针对每种结果类型想要了解哪些具体信息,以及她们想要了解多少信息。基因组测序并非作为研究的一部分提供给参与者。两名编码员独立对访谈记录进行编码;使用NVivo10进行分析。在不同结果类型中,参与者希望了解健康影响、定量的风险和患病率、变异的原因以及疾病的病因。对于影响可预防或可治疗疾病风险、药物反应和携带者状态的变异,参与者希望了解可采取行动的信息。对于影响不可预防或不可治疗疾病风险、意义不确定且与健康无关的变异,所需信息的数量有所不同。年轻时被诊断出患有乳腺癌的女性认识到基因组测序结果在识别潜在病因和有效治疗方法方面的价值,并表示有兴趣利用这些信息帮助亲属并进一步了解自己的其他健康风险。我们的研究结果可为制定满足患者信息需求和偏好的基因组测序有效反馈策略提供参考。

相似文献

4
How, who, and when: preferences for delivery of genome sequencing results among women diagnosed with breast cancer at a young age.
Mol Genet Genomic Med. 2016 Oct 24;4(6):684-695. doi: 10.1002/mgg3.254. eCollection 2016 Nov.
5
Impact of numeracy preferences on information needs for genome sequencing results.
Patient Educ Couns. 2021 Mar;104(3):467-472. doi: 10.1016/j.pec.2020.09.032. Epub 2020 Sep 25.
6
Decision role preferences for return of results from genome sequencing amongst young breast cancer patients.
Patient Educ Couns. 2019 Jan;102(1):155-161. doi: 10.1016/j.pec.2018.08.004. Epub 2018 Aug 4.
7
Noninvasive Prenatal Whole Genome Sequencing: Pregnant Women's Views and Preferences.
Obstet Gynecol. 2019 Mar;133(3):525-532. doi: 10.1097/AOG.0000000000003121.
9
When bins blur: Patient perspectives on categories of results from clinical whole genome sequencing.
AJOB Empir Bioeth. 2017 Apr-Jun;8(2):82-88. doi: 10.1080/23294515.2017.1287786. Epub 2017 Jan 27.
10
Living into old age with the consequences of breast cancer.
Eur J Oncol Nurs. 2013 Jun;17(3):311-6. doi: 10.1016/j.ejon.2012.08.004. Epub 2012 Sep 1.

引用本文的文献

1
2
Assessing patient readiness for personalized genomic medicine.
J Community Genet. 2019 Jan;10(1):109-120. doi: 10.1007/s12687-018-0365-5. Epub 2018 May 26.
3
How do providers discuss the results of pediatric exome sequencing with families?
Per Med. 2017 Sep;14(5):409-422. doi: 10.2217/pme-2017-0015. Epub 2017 Sep 4.

本文引用的文献

1
Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine.
Am J Hum Genet. 2016 Jun 2;98(6):1051-1066. doi: 10.1016/j.ajhg.2016.04.011. Epub 2016 May 12.
4
A systematic approach to the reporting of medically relevant findings from whole genome sequencing.
BMC Med Genet. 2014 Dec 14;15:134. doi: 10.1186/s12881-014-0134-1.
5
Next-generation sequencing of the BRCA1 and BRCA2 genes for the genetic diagnostics of hereditary breast and/or ovarian cancer.
J Mol Diagn. 2015 Mar;17(2):162-70. doi: 10.1016/j.jmoldx.2014.11.004. Epub 2014 Dec 31.
6
The role of genome sequencing in personalized breast cancer prevention.
Cancer Epidemiol Biomarkers Prev. 2014 Nov;23(11):2322-7. doi: 10.1158/1055-9965.EPI-14-0559.
7
Retrospective analysis of 18F-FDG PET/CT for staging asymptomatic breast cancer patients younger than 40 years.
J Nucl Med. 2014 Oct;55(10):1578-83. doi: 10.2967/jnumed.114.143297. Epub 2014 Sep 11.
8
"We don't know her history, her background": adoptive parents' perspectives on whole genome sequencing results.
J Genet Couns. 2015 Feb;24(1):67-77. doi: 10.1007/s10897-014-9738-z. Epub 2014 Jul 12.
10
Diagnostic clinical genome and exome sequencing.
N Engl J Med. 2014 Jun 19;370(25):2418-25. doi: 10.1056/NEJMra1312543.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验